SPY365.03+2.97 0.82%
DIA299.18+2.56 0.86%
IXIC12,273.98+75.24 0.62%

Prevail Therapeutics Q3 EPS $(0.55) Up From $(0.62) YoY

Prevail Therapeutics (NASDAQ:PRVL) reported quarterly losses of $(0.55) per share. This is a 11.29 percent increase over losses of $(0.62) per share from the same period last year.

· 11/13/2020 07:07
Prevail Therapeutics (NASDAQ:PRVL) reported quarterly losses of $(0.55) per share. This is a 11.29 percent increase over losses of $(0.62) per share from the same period last year.